TABLE 10. Estimated percent using inhaled short acting beta agonists among adults1 with current2 or active3 asthma status by state/territory – BRFSS Asthma Call-back Survey, United States, 2009

State/Territory Current Active
Sample
size±
% SE§ 95% CI Sample
size
% SE 95% CI
Arizona 113 60.7 7.2 (46.6 – 74.8) 118 62.1 6.7 (49.0 – 75.2)
California 517 56.5 3.3 (50.0 – 63.0) 549 52.3 3.5 (45.4 – 59.2)
Connecticut 235 56.4 5.0 (46.6 – 66.2) 257 54.3 4.7 (45.1 – 63.5)
District of Columbia 134 57.1 5.7 (45.9 – 68.3) 151 52.0 5.4 (41.4 – 62.6)
Florida 416 50.2 4.6 (41.2 – 59.2) 454 44.8 4.9 (35.2 – 54.4)
Georgia 192 52.9 6.0 (41.1 – 64.7) 198 46.3 6.4 (33.8 – 58.8)
Hawaii 278 55.7 4.7 (46.5 – 64.9) 275 58.2 4.5 (49.4 – 67.0)
Illinois 185 57.4 5.1 (47.4 – 67.4) 204 53.5 5.0 (43.7 – 63.3)
Indiana 391 57.7 4.2 (49.5 – 65.9) 426 53.6 4.0 (45.8 – 61.4)
Iowa 233 47.9 5.1 (37.9 – 57.9) 247 44.0 4.8 (34.6 – 53.4)
Kansas 828 54.6 2.9 (48.9 – 60.3) 885 54.1 2.7 (48.8 – 59.4)
Louisiana 196 43.8 6.3 (31.5 – 56.1) 218 40.5 5.8 (29.1 – 51.9)
Maine 235 63.1 4.8 (53.7 – 72.5) 254 61.1 4.5 (52.3 – 69.9)
Maryland 267 45.5 5.5 (34.7 – 56.3) 289 41.5 4.9 (31.9 – 51.1)
Massachusetts 225 58.6 5.4 (48.0 – 69.2) 252 52.5 5.3 (42.1 – 62.9)
Michigan 471 52.9 3.7 (45.6 – 60.2) 531 47.4 3.4 (40.7 – 54.1)
Montana 307 53.0 5.0 (43.2 – 62.8) 318 55.1 4.7 (45.9 – 64.3)
Nebraska 540 47.9 4.3 (39.5 – 56.3) 548 49.5 4.2 (41.3 – 57.7)
Nevada 131 53.5 8.7 (36.4 – 70.6) 139 52.1 8.4 (35.6 – 68.6)
New Hampshire 259 48.5 4.9 (38.9 – 58.1) 283 45.5 4.7 (36.3 – 54.7)
New Jersey 360 51.4 4.5 (42.6 – 60.2) 392 48.7 4.4 (40.1 – 57.3)
New Mexico 205 62.1 4.7 (52.9 – 71.3) 226 56.6 4.8 (47.2 – 66.0)
New York 326 57.6 4.9 (48.0 – 67.2) 357 53.7 4.7 (44.5 – 62.9)
North Dakota 190 58.7 5.3 (48.3 – 69.1) 200 59.0 4.9 (49.4 – 68.6)
Ohio 276 48.6 5.3 (38.2 – 59.0) 299 48.3 5.1 (38.3 – 58.3)
Oklahoma 283 58.7 4.7 (49.5 – 67.9) 293 57.7 4.6 (48.7 – 66.7)
Oregon 149 59.5 5.9 (47.9 – 71.1) 164 53.7 5.7 (42.5 – 64.9)
Rhode Island 302 57.3 5.0 (47.5 – 67.1) 326 54.7 4.9 (45.1 – 64.3)
Texas 472 38.7 4.2 (30.5 – 46.9) 505 33.4 3.7 (26.1 – 40.7)
Utah 433 48.1 3.8 (40.7 – 55.5) 481 45.4 3.7 (38.1 – 52.7)
Vermont 360 53.8 4.7 (44.6 – 63.0) 385 52.7 4.5 (43.9 – 61.5)
Virginia 183 41.8 6.1 (29.8 – 53.8) 189 40.4 5.9 (28.8 – 52.0)
Washington 491 58.7 3.8 (51.3 – 66.1) 533 54.6 3.6 (47.5 – 61.7)
West Virginia 248 64.2 4.3 (55.8 – 72.6) 257 66.3 4.1 (58.3 – 74.3)
Wisconsin 223 58.5 5.7 (47.3 – 69.7) 235 56.0 5.6 (45.0 – 67.0)
Puerto Rico 165 30.9 4.9 (21.3 – 40.5) 245 26.9 4.0 (19.1 – 34.7)
36 state total 10,819 53.1 1.1 (50.9 – 55.3) 11,683 49.3 1.1 (47.1 – 51.5)
Median   55.2       52.6    
Range   30.9-64.2       26.9-66.3    

1 Aged ≥ 18 years

2 “Yes” response to “Do you still have asthma?”

3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma

± Sample size excludes “DK/Refused”

§ Standard error

Confidence interval